HG
Hideki Garren
Psychiatry & Neurology / Neurology
Credentials: ·
Research
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
New England Journal of Medicine · 2017 · 1,531 citations
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
New England Journal of Medicine · 2017 · 1,412 citations
Nature Medicine · 2002 · 1,342 citations
24 papers
8 papers · 1 as a fellow
5 papers
5 papers
4 papers
4 papers
4 papers
3 papers · 3 as a resident
